Biondo Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,450
Closed -$293K 92
2017
Q4
$293K Buy
+5,450
New +$302K 0.07% 89
2015
Q3
Sell
-11,738
Closed -$638K 85
2015
Q2
$638K Hold
11,738
0.19% 58
2015
Q1
$644K Hold
11,738
0.19% 56
2014
Q4
$636K Hold
11,738
0.19% 56
2014
Q3
$664K Hold
11,738
0.2% 58
2014
Q2
$648K Hold
11,738
0.2% 60
2014
Q1
$636K Sell
11,738
-209
-2% -$10.8K 0.21% 64
2013
Q4
$571K Buy
11,947
+209
+2% +$9.55K 0.2% 67
2013
Q3
$533K Sell
11,738
-157
-1% -$7.17K 0.2% 67
2013
Q2
$527K Buy
+11,895
New +$531K 0.23% 69

Other funds holding MRK

Biondo Investment Advisors's MRK Position: Q1 2018 in Review

Biondo Investment Advisors sold out of Merck (MRK) in Q1 2018, closing a stake of 5,450 shares — an estimated $293K sold.

Biondo Investment Advisors first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $664K in Q3 2014. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Biondo Investment Advisors reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • Biondo Investment Advisors sold 5,450 Merck shares in Q1 2018, an estimated $293K.
  • Biondo Investment Advisors first reported a position in Merck in Q2 2013 and held it in 10 quarters.
  • Biondo Investment Advisors's Merck position peaked at $664K in Q3 2014.
  • 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Biondo Investment Advisors's 13F filing for Q1 2018, filed 2 May 2018.